NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268958. A total of 5 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,685,000 | -90.6% | 817 | -82.6% | 0.59% | -83.8% |
| Q3 2018 | $28,560,000 | +96.5% | 4,685 | +57.4% | 3.66% | +62.7% |
| Q2 2018 | $14,537,000 | +144.3% | 2,977 | +431.6% | 2.25% | +532.7% |
| Q1 2018 | $5,950,000 | +236.0% | 560 | -61.7% | 0.36% | +258.6% |
| Q1 2014 | $1,771,000 | +873.1% | 1,461 | +813.1% | 0.10% | +725.0% |
| Q4 2013 | $182,000 | -80.7% | 160 | -82.2% | 0.01% | -80.3% |
| Q3 2013 | $941,000 | – | 900 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 817 | $2,685,000 | 0.59% |
| GROUP ONE TRADING, L.P. | 85,800 | $2,820,000 | 0.02% |
| SIMPLEX TRADING, LLC | 270 | $887,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 40,000 | $1,315,000 | 0.00% |